COMPANY
Ankasa Regenerative Therapeutics
Timeline
- Trial start Phase 1/Phase 2: Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT04378543 | Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion | Phase 1/Phase 2 | Unknown status (ClinicalTrials.gov) | Sep 30, 2020 | 2022-04 (estimated) |